FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• Nexium (esomeprazole)

Snippet

SUPPL AP for NEXIUM (ESOMEPRAZOLE MAGNESIUM)